Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Clin Cancer Res April 15 2013 19 (8) 1915-1915;

CCR Translations

  • CCR Translations
    Zoom Zoom: Racing CARs for Multiple Myeloma
    Marcela V. Maus and Carl H. June
    Clin Cancer Res April 15 2013 19 (8) 1917-1919; DOI:10.1158/1078-0432.CCR-13-0168

CCR Drug Updates

  • CCR Drug Updates
    Aflibercept
    Kristen K. Ciombor, Jordan Berlin and Emily Chan
    Clin Cancer Res April 15 2013 19 (8) 1920-1925; DOI:10.1158/1078-0432.CCR-12-2911

Molecular Pathways

  • Molecular Pathways
    Molecular Pathways: Adiponectin and Leptin Signaling in Cancer
    Michael N. VanSaun
    Clin Cancer Res April 15 2013 19 (8) 1926-1932; DOI:10.1158/1078-0432.CCR-12-0930

  • Molecular Pathways
    Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
    Alfonso Quintás-Cardama and Srdan Verstovsek
    Clin Cancer Res April 15 2013 19 (8) 1933-1940; DOI:10.1158/1078-0432.CCR-12-0284

Tobacco Statement

  • Tobacco Statement | Free Article
    Assessing Tobacco Use by Cancer Patients and Facilitating Cessation: An American Association for Cancer Research Policy Statement
    Benjamin A. Toll, Thomas H. Brandon, Ellen R. Gritz, Graham W. Warren and Roy S. Herbst; Writing Committee for the AACR Subcommittee on Tobacco and Cancer
    Clin Cancer Res April 15 2013 19 (8) 1941-1948; DOI:10.1158/1078-0432.CCR-13-0666

Human Cancer Biology

  • Human Cancer Biology
    C-Reactive Protein Downregulates TRAIL Expression in Human Peripheral Monocytes via an Egr-1–Dependent Pathway
    Paola Secchiero, Erika Rimondi, Maria Grazia di Iasio, Chiara Agnoletto, Elisabetta Melloni, Ilaria Volpi and Giorgio Zauli
    Clin Cancer Res April 15 2013 19 (8) 1949-1959; DOI:10.1158/1078-0432.CCR-12-3027

  • Human Cancer Biology
    Copy Number Aberrations of Genes Regulating Normal Thymus Development in Thymic Epithelial Tumors
    Iacopo Petrini, Yisong Wang, Paolo A. Zucali, Hye Seung Lee, Trung Pham, Donna Voeller, Paul S. Meltzer and Giuseppe Giaccone
    Clin Cancer Res April 15 2013 19 (8) 1960-1971; DOI:10.1158/1078-0432.CCR-12-3260

  • Human Cancer Biology
    Notch Pathway Activity Identifies Cells with Cancer Stem Cell–like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
    Khaled A. Hassan, Luo Wang, Hasan Korkaya, Guoan Chen, Ivan Maillard, David G. Beer, Gregory P. Kalemkerian and Max S. Wicha
    Clin Cancer Res April 15 2013 19 (8) 1972-1980; DOI:10.1158/1078-0432.CCR-12-0370

  • Human Cancer Biology
    Aberrant Expression of Mucin Core Proteins and O-Linked Glycans Associated with Progression of Pancreatic Cancer
    Neeley Remmers, Judy M. Anderson, Erin M. Linde, Dominick J. DiMaio, Audrey J. Lazenby, Hans H. Wandall, Ulla Mandel, Henrik Clausen, Fang Yu and Michael A. Hollingsworth
    Clin Cancer Res April 15 2013 19 (8) 1981-1993; DOI:10.1158/1078-0432.CCR-12-2662

  • Human Cancer Biology
    Functional Genetic Screens Identify Genes Essential for Tumor Cell Survival in Head and Neck and Lung Cancer
    Sanne R. Martens-de Kemp, Remco Nagel, Marijke Stigter-van Walsum, Ida H. van der Meulen, Victor W. van Beusechem, Boudewijn J.M. Braakhuis and Ruud H. Brakenhoff
    Clin Cancer Res April 15 2013 19 (8) 1994-2003; DOI:10.1158/1078-0432.CCR-12-2539

  • Human Cancer Biology
    Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)
    Hidetoshi Nitta, Yoshihiro Wada, Yoshiaki Kawano, Yoji Murakami, Atsushi Irie, Keisuke Taniguchi, Ken Kikuchi, Gen Yamada, Kentaro Suzuki, Jiro Honda, Masayo Wilson-Morifuji, Norie Araki, Masatoshi Eto, Hideo Baba and Takahisa Imamura
    Clin Cancer Res April 15 2013 19 (8) 2004-2013; DOI:10.1158/1078-0432.CCR-12-1204

  • Human Cancer Biology
    The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma
    Liang Tang, Ye-Xiong Tan, Bei-Ge Jiang, Yu-Fei Pan, Shuang-Xi Li, Guang-Zhen Yang, Min Wang, Qing Wang, Jian Zhang, Wei-Ping Zhou, Li-Wei Dong and Hong-Yang Wang
    Clin Cancer Res April 15 2013 19 (8) 2014-2024; DOI:10.1158/1078-0432.CCR-12-0349

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Targeting the NF-κB and mTOR Pathways with a Quinoxaline Urea Analog That Inhibits IKKβ for Pancreas Cancer Therapy
    Prakash Radhakrishnan, Vashti C. Bryant, Elizabeth C. Blowers, Rajkumar N. Rajule, Nagsen Gautam, Muhammad M. Anwar, Ashley M. Mohr, Paul M. Grandgenett, Stephanie K. Bunt, Jamie L. Arnst, Subodh M. Lele, Yazen Alnouti, Michael A. Hollingsworth and Amarnath Natarajan
    Clin Cancer Res April 15 2013 19 (8) 2025-2035; DOI:10.1158/1078-0432.CCR-12-2909

  • Cancer Therapy: Preclinical | AuthorChoice
    hTERT Inhibition Triggers Epstein–Barr Virus Lytic Cycle and Apoptosis in Immortalized and Transformed B Cells: A Basis for New Therapies
    Silvia Giunco, Riccardo Dolcetti, Sonia Keppel, Andrea Celeghin, Stefano Indraccolo, Jessica Dal Col, Katy Mastorci and Anita De Rossi
    Clin Cancer Res April 15 2013 19 (8) 2036-2047; DOI:10.1158/1078-0432.CCR-12-2537

  • Cancer Therapy: Preclinical
    B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
    Robert O. Carpenter, Moses O. Evbuomwan, Stefania Pittaluga, Jeremy J. Rose, Mark Raffeld, Shicheng Yang, Ronald E. Gress, Frances T. Hakim and James N. Kochenderfer
    Clin Cancer Res April 15 2013 19 (8) 2048-2060; DOI:10.1158/1078-0432.CCR-12-2422

  • Cancer Therapy: Preclinical | Free Article
    A Targeted RNAi Screen of the Breast Cancer Genome Identifies KIF14 and TLN1 as Genes That Modulate Docetaxel Chemosensitivity in Triple-Negative Breast Cancer
    Stina Mui Singel, Crystal Cornelius, Kimberly Batten, Gail Fasciani, Woodring E. Wright, Lawrence Lum and Jerry W. Shay
    Clin Cancer Res April 15 2013 19 (8) 2061-2070; DOI:10.1158/1078-0432.CCR-13-0082

  • Cancer Therapy: Preclinical
    Extracellular Signal–Regulated Kinase 5: A Potential Therapeutic Target for Malignant Mesotheliomas
    Arti Shukla, Jill M. Miller, Christopher Cason, Mutlay Sayan, Maximilian B. MacPherson, Stacie L. Beuschel, Jedd Hillegass, Pamela M. Vacek, Harvey I. Pass and Brooke T. Mossman
    Clin Cancer Res April 15 2013 19 (8) 2071-2083; DOI:10.1158/1078-0432.CCR-12-3202

  • Cancer Therapy: Preclinical
    Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues
    Fan Lin, Serena Marchetti, Dick Pluim, Dilek Iusuf, Roberto Mazzanti, Jan H.M. Schellens, Jos H. Beijnen and Olaf van Tellingen
    Clin Cancer Res April 15 2013 19 (8) 2084-2095; DOI:10.1158/1078-0432.CCR-12-3105

  • Cancer Therapy: Preclinical
    Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
    Emanuela Leone, Eugenio Morelli, Maria T. Di Martino, Nicola Amodio, Umberto Foresta, Annamaria Gullà, Marco Rossi, Antonino Neri, Antonio Giordano, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri and Pierfrancesco Tassone
    Clin Cancer Res April 15 2013 19 (8) 2096-2106; DOI:10.1158/1078-0432.CCR-12-3325

  • Cancer Therapy: Preclinical
    Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78
    Yu Rebecca Miao, Bedrich L. Eckhardt, Yuan Cao, Renata Pasqualini, Pedram Argani, Wadih Arap, Robert G. Ramsay and Robin L. Anderson
    Clin Cancer Res April 15 2013 19 (8) 2107-2116; DOI:10.1158/1078-0432.CCR-12-2991

  • Cancer Therapy: Preclinical
    The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models
    Ymera Pignochino, Carmine Dell'Aglio, Marco Basiricò, Federica Capozzi, Marco Soster, Serena Marchiò, Stefania Bruno, Loretta Gammaitoni, Dario Sangiolo, Erica Torchiaro, Lorenzo D'Ambrosio, Franca Fagioli, Stefano Ferrari, Marco Alberghini, Piero Picci, Massimo Aglietta and Giovanni Grignani
    Clin Cancer Res April 15 2013 19 (8) 2117-2131; DOI:10.1158/1078-0432.CCR-12-2293

  • Cancer Therapy: Preclinical | AuthorChoice
    Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
    Yin Liu, Hong-Wei Wu, Michael A. Sheard, Richard Sposto, Srinivas S. Somanchi, Laurence J.N. Cooper, Dean A. Lee and Robert C. Seeger
    Clin Cancer Res April 15 2013 19 (8) 2132-2143; DOI:10.1158/1078-0432.CCR-12-1243

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Mammographic Breast Density Response to Aromatase Inhibition
    Celine M. Vachon, Vera J. Suman, Kathleen R. Brandt, Matthew L. Kosel, Aman U. Buzdar, Janet E. Olson, Fang-Fang Wu, Lynn M. Flickinger, Giske Ursin, Catherine R. Elliott, Lois Shepherd, Richard M. Weinshilboum, Paul E. Goss and James N. Ingle
    Clin Cancer Res April 15 2013 19 (8) 2144-2153; DOI:10.1158/1078-0432.CCR-12-2789

  • Imaging, Diagnosis, Prognosis
    Potentially Prognostic miRNAs in HPV-Associated Oropharyngeal Carcinoma
    Angela B.Y. Hui, Alice Lin, Wei Xu, Levi Waldron, Bayardo Perez-Ordonez, Ilan Weinreb, Wei Shi, Jeff Bruce, Shao Hui Huang, Brian O'Sullivan, John Waldron, Patrick Gullane, Jonathan C. Irish, Kelvin Chan and Fei-Fei Liu
    Clin Cancer Res April 15 2013 19 (8) 2154-2162; DOI:10.1158/1078-0432.CCR-12-3572

  • Imaging, Diagnosis, Prognosis
    Quantitative Ultrasound Evaluation of Tumor Cell Death Response in Locally Advanced Breast Cancer Patients Receiving Chemotherapy
    Ali Sadeghi-Naini, Naum Papanicolau, Omar Falou, Judit Zubovits, Rebecca Dent, Sunil Verma, Maureen Trudeau, Jean Francois Boileau, Jacqueline Spayne, Sara Iradji, Ervis Sofroni, Justin Lee, Sharon Lemon-Wong, Martin Yaffe, Michael C. Kolios and Gregory J. Czarnota
    Clin Cancer Res April 15 2013 19 (8) 2163-2174; DOI:10.1158/1078-0432.CCR-12-2965

  • Imaging, Diagnosis, Prognosis
    Epstein-Barr Virus DNA Load in Nasopharyngeal Brushings and Whole Blood in Nasopharyngeal Carcinoma Patients before and after Treatment
    Marlinda Adham, Astrid E. Greijer, Sandra A.W.M. Verkuijlen, Hedy Juwana, Sabine Fleig, Lisnawati Rachmadi, Octavia Malik, A.N. Kurniawan, Averdi Roezin, Soehartati Gondhowiardjo, Djumhana Atmakusumah, Servi J.C. Stevens, Bambang Hermani, I. Bing Tan and Jaap M. Middeldorp
    Clin Cancer Res April 15 2013 19 (8) 2175-2186; DOI:10.1158/1078-0432.CCR-12-2897

  • Imaging, Diagnosis, Prognosis
    MicroRNA Profiling Can Classify Acute Leukemias of Ambiguous Lineage as Either Acute Myeloid Leukemia or Acute Lymphoid Leukemia
    David C. de Leeuw, Willemijn van den Ancker, Fedor Denkers, Renée X. de Menezes, Theresia M. Westers, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht and Linda Smit
    Clin Cancer Res April 15 2013 19 (8) 2187-2196; DOI:10.1158/1078-0432.CCR-12-3657

  • Imaging, Diagnosis, Prognosis
    CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids
    Dorian R.A. Swarts, Mieke E.R. Henfling, Leander Van Neste, Robert-Jan van Suylen, Anne-Marie C. Dingemans, Winand N.M. Dinjens, Annick Haesevoets, Martina Rudelius, Erik Thunnissen, Marco Volante, Wim Van Criekinge, Manon van Engeland, Frans C.S. Ramaekers and Ernst-Jan M. Speel
    Clin Cancer Res April 15 2013 19 (8) 2197-2207; DOI:10.1158/1078-0432.CCR-12-3078

  • Imaging, Diagnosis, Prognosis
    An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma
    Quynh-Thu Le, Qiang Zhang, Hongbin Cao, Ann-Joy Cheng, Benjamin A. Pinsky, Ruey-Long Hong, Joseph T. Chang, Chun-Wei Wang, Kuo-Chien Tsao, YM Dennis Lo, Nancy Lee, K. Kian Ang, Anthony T.C. Chan and K.C. Allen Chan
    Clin Cancer Res April 15 2013 19 (8) 2208-2215; DOI:10.1158/1078-0432.CCR-12-3702

  • Imaging, Diagnosis, Prognosis
    Methylation of the hTERT Promoter: A Novel Cancer Biomarker for Leptomeningeal Metastasis Detection in Cerebrospinal Fluids
    Stéphanie Bougel, Benoit Lhermitte, Gabrielle Gallagher, Jeanne-Chantal de Flaugergues, Robert C. Janzer and Jean Benhattar
    Clin Cancer Res April 15 2013 19 (8) 2216-2223; DOI:10.1158/1078-0432.CCR-12-1246

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
    Atsushi Aruga, Nobuhiro Takeshita, Yoshihito Kotera, Ryuji Okuyama, Norimasa Matsushita, Takehiro Ohta, Kazuyoshi Takeda and Masakazu Yamamoto
    Clin Cancer Res April 15 2013 19 (8) 2224-2231; DOI:10.1158/1078-0432.CCR-12-3592

  • Cancer Therapy: Clinical
    Efficacy and Safety of Retreatment with Ipilimumab in Patients with Pretreated Advanced Melanoma Who Progressed after Initially Achieving Disease Control
    Caroline Robert, Dirk Schadendorf, Marianne Messina, F. Stephen Hodi and Steven O'Day; for the MDX010-20 investigators
    Clin Cancer Res April 15 2013 19 (8) 2232-2239; DOI:10.1158/1078-0432.CCR-12-3080

  • Cancer Therapy: Clinical
    Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
    Helena A. Yu, Maria E. Arcila, Natasha Rekhtman, Camelia S. Sima, Maureen F. Zakowski, William Pao, Mark G. Kris, Vincent A. Miller, Marc Ladanyi and Gregory J. Riely
    Clin Cancer Res April 15 2013 19 (8) 2240-2247; DOI:10.1158/1078-0432.CCR-12-2246

  • Cancer Therapy: Clinical
    Phase Ib Dose-Escalation Study (PX-171-006) of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Progressive Multiple Myeloma
    Ruben Niesvizky, Thomas G. Martin III, William I. Bensinger, Melissa Alsina, David S. Siegel, Lori A. Kunkel, Alvin F. Wong, Susan Lee, Robert Z. Orlowski and Michael Wang
    Clin Cancer Res April 15 2013 19 (8) 2248-2256; DOI:10.1158/1078-0432.CCR-12-3352

Predictive Biomarkers and Personalized Medicine

  • Predictive Biomarkers and Personalized Medicine
    Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma
    Federica Catalanotti, David B. Solit, Melissa P. Pulitzer, Michael F. Berger, Sasinya N. Scott, Tunc Iyriboz, Mario E. Lacouture, Katherine S. Panageas, Jedd D. Wolchok, Richard D. Carvajal, Gary K. Schwartz, Neal Rosen and Paul B. Chapman
    Clin Cancer Res April 15 2013 19 (8) 2257-2264; DOI:10.1158/1078-0432.CCR-12-3476

  • Predictive Biomarkers and Personalized Medicine
    Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer
    Alessio Amatu, Andrea Sartore-Bianchi, Catia Moutinho, Alessandro Belotti, Katia Bencardino, Giuseppe Chirico, Andrea Cassingena, Francesca Rusconi, Anna Esposito, Michele Nichelatti, Manel Esteller and Salvatore Siena
    Clin Cancer Res April 15 2013 19 (8) 2265-2272; DOI:10.1158/1078-0432.CCR-12-3518

Correction

  • Correction
    Correction: Polyphenon E Enhances the Antitumor Immune Response in Neuroblastoma by Inactivating Myeloid Suppressor Cells
    Clin Cancer Res April 15 2013 19 (8) 2273-2273; DOI:10.1158/1078-0432.CCR-13-0727

Back to top
PreviousNext
Clinical Cancer Research: 19 (8)
April 2013
Volume 19, Issue 8
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
  • A Targeted RNAi Screen of the Breast Cancer Genome Identifies KIF14 and TLN1 as Genes That Modulate Docetaxel Chemosensitivity in Triple-Negative Breast Cancer
  • hTERT Inhibition Triggers Epstein–Barr Virus Lytic Cycle and Apoptosis in Immortalized and Transformed B Cells: A Basis for New Therapies
  • The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models
  • Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer

Jump to

  • Highlights
  • CCR Translations
  • CCR Drug Updates
  • Molecular Pathways
  • Tobacco Statement
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Predictive Biomarkers and Personalized Medicine
  • Correction
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement